Hypertension drug may slow brain disease in children
A study from the University of Amsterdam has revealed that the medication "Guanabenz," used to treat high blood pressure, may help slow the progression of the hereditary "White Matter Disease" in children. This disease causes gradual loss of motor and cognitive abilities and can lead to early death. The study was conducted on 66 children affected by the condition and showed that those treated with "Guanabenz" relied less and more slowly on wheelchairs, despite experiencing side effects such as hallucinations and drowsiness. None of the treated children died, whereas five of the untreated ones did. The findings confirm that while the treatment does not cure the disease, it shows potential for a positive impact on its progression. A follow-up study is currently underway to monitor the effects of higher dosages.
Notice: This Is an AI-Generated Summary
Comments (0)